Top Markets
Coin of the day
Bonesupport Holding AB (publ) Bonesupport Holding AB (publ)

Bonesupport Holding AB (publ)

BONEX
Rang in Aktien #7240
Bonesupport Holding AB (publ) is an orthobiologics company that specializes in... Bonesupport Holding AB (publ) is an orthobiologics company that specializes in the development and commercialization of injectable bioceramic bone graft substitutes. These products are utilized for treating bone voids and are available internationally, including in Europe and North America. Among its key offerings are CERAMENT Bone Void Filler, a synthetic, injectable, moldable, and drillable solution comprising hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol. Additionally, the company provides CERAMENT G, an injectable ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic bone void filler containing vancomycin. Bonesupport is also advancing preclinical product candidates focused on promoting bone regrowth. These future solutions are being developed for applications such as trauma, revision arthroplasty, chronic osteomyelitis, oncology, and bone and foot infections related to diabetes. Founded in 1999, the company maintains its headquarters in Lund, Sweden.
Aktienkurs
$25.42
Marktkapitalisierung
$1.66B
Veränderung (1 Tag)
-0.09%
Veränderung (1 Jahr)
-22.92%
Land
SE
Handel Bonesupport Holding AB (publ) (BONEX)

Kategorie

Kursverlauf für Bonesupport Holding AB (publ) (BONEX)
Höchster Schlusskurs: $25.07 am 2026-08-01

Niedrigster Schlusskurs: $3.44 am 2017-06-01
Kursverlauf der Aktie von Bonesupport Holding AB (publ) von 2017 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 22.81%
2025 -40.63%
2024 90.81%
2023 120.49%
2022 86.80%
2021 -52.60%
2020 161.92%
2019 60.18%
2018 -9.49%
2017 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$111.46 -15.16%
US
$322.23 -17.31%
US
$90.06 -2.07%
IE
$46.67 -55.87%
US
$47.02 -14.98%
DE